Status:
UNKNOWN
Managing Stress With Inflammatory Bowel Disease
Lead Sponsor:
University of Manitoba
Conditions:
Inflammatory Bowel Disease
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will recruit persons with Inflammatory Bowel Disease. The investigators will contact people in an ongoing study (called IMAGINE) to recruit persons with high levels of stress, anxiety, or d...
Detailed Description
Depression and anxiety are highly prevalent in IBD, with depression rates almost twice as high for those with IBD compared to the general community, and an estimated 30% overall with depression or anx...
Eligibility Criteria
Inclusion
- Diagnosed with inflammatory bowel disease - Crohn's disease or ulcerative colitis
- A score on a scale measuring perceived stress, anxiety or depression indicating the presence of a clinically significant problem
- Regular access to a personal computer and Internet to allow access to the program
- Ability to read and write English
Exclusion
- Presence of significant suicidal ideation or suicidal intent within the last six months
- Presence of self-harming behavior in the last six months
- Currently active substance use disorder (last six months)
- Psychotic disorder (last six months)
- Eating disorder (last six months)
Key Trial Info
Start Date :
April 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03852745
Start Date
April 18 2019
End Date
December 31 2022
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manitoba - College of Medicine
Winnipeg, Manitoba, Canada, R3E 0W2